drugset / Trial / NCT04357223

NOGO for an Overactive Bladder

NCT04357223 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double-blind, randomized and placebo-controlled study to evaluate the safety and effectiveness of NoGo, a standardized extract from Angelica archangelica, on overactive bladder

Timeline

Start
2020-05-01
Primary completion
2021-02-01
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Angelica archangelica (AA) leaf extract Unknown — —

Indications